Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 4/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GLS | O94925 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 2/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23533636 | 1.00 | KMO (0.44) | KMOMAOBMAOANPC1RAB9A | |
| SCHEMBL14910174 | 0.82 | MAOB (0.51) | KMOMAOBMAOANPC1RAB9A | |
| SCHEMBL16931273 | 0.80 | GLS (0.64) | KMOMAOBMAOANPC1GLS | |
| SCHEMBL23348499 | 0.78 | KMO (0.43) | KMOMAOBMAOANPC1RAB9A | |
| SCHEMBL14910114 | 0.77 | KMO (0.42) | KMOMAOBMAOANPC1RAB9A | |
| SCHEMBL13548 | 0.77 | KMO (0.49) | KMONPC1RAB9AGLSHDAC8 | |
| SCHEMBL23546502 | 0.76 | KMO (0.41) | KMOMAOBMAOANPC1RAB9A | |
| SCHEMBL21780863 | 0.76 | KMO (0.41) | KMOMAOBMAOANPC1RAB9A | |
| SCHEMBL27165385 | 0.76 | HTR2A (0.51) | KMOHTR2AHTR2C | |
| SCHEMBL27165379 | 0.75 | HTR2A (0.54) | KMONPC1RAB9AKMT2AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4076662-A1 | PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS | Novartis AG (CH) | 2022-10-26 | — | — | EP | disclosed |